Is Vivakor Inc (VIVK) Stock a Good Buy for Short-term Investors?

A share price of Vivakor Inc [VIVK] is currently trading at $0.85, up 16.11%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VIVK shares have gain 8.95% over the last week, with a monthly amount drifted -20.24%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Vivakor Inc experienced fluctuations in its stock price throughout the past year between $0.55 and $3.45. Vivakor Inc [NASDAQ: VIVK] shares were valued at $0.85 at the most recent close of the market.

Analyzing the VIVK fundamentals

Trailing Twelve Months sales for Vivakor Inc [NASDAQ:VIVK] were 111.13M which represents 133.07% growth. Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at -0.24%, Pretax Profit Margin comes in at -0.29%, and Net Profit Margin reading is -0.25%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.53 and Total Capital is -0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.67.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7511 points at the first support level, and at 0.6523 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.9193, and for the 2nd resistance point, it is at 0.9887.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Vivakor Inc [NASDAQ:VIVK] is 0.22. As well, the Quick Ratio is 0.22, while the Cash Ratio is 0.01. Considering the valuation of this stock, the price to sales ratio is 0.36, the price to book ratio is 0.34.

Transactions by insiders

Recent insider trading involved Ballengee James H., Chairman, President, & CEO, that happened on May 31 ’24 when 12612.0 shares were purchased. Chairman, President, & CEO, Ballengee James H. completed a deal on Jun 03 ’24 to buy 1000.0 shares.

Related Posts

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.